Jeff Geschwind, MD: Innovator in Drug Development Jeff Geschwind, MD, is the founder of Cage Pharma. His entrepreneurial spirit focuses on creating new cancer drugs that target tumor metabolism, demonstrating his commitment to attacking cancer from multiple scientific fronts. https://www.onclive.com/authors/jeff-geschwind-md-johns-hopkins